Business Context and Reporting Period
This Form 8-K Current Report was filed by Herbalife Ltd. on March 23, 2018. The filing discloses the creation of a direct financial obligation through the issuance of convertible senior notes.
Key Financial Metrics
- Debt Issuance: $550 million aggregate principal amount of 2.625% Convertible Senior Notes due 2024.
- Interest Rate: 2.625% per annum, payable semiannually in arrears beginning September 15, 2018.
- Maturity Date: March 15, 2024.
- Conversion Price: Approximately $124.96 per common share (initial conversion rate of 8.0028 shares per $1,000 principal).
- Underwriting Discounts: Approximately $11.7 million paid to initial purchasers.
- Revenue, Profit, Cash Flow, Margins, Liquidity: The filing text does not provide a clear value for these operational metrics as this is a transaction-specific report.
Material Changes
The primary material change is the addition of $550 million in convertible debt to the company's capital structure. The notes were offered and sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.
Guidance, Outlook, and Risks
- Conversion Terms: Notes are convertible into cash, common shares, or a combination at Herbalife's election. Holders may convert freely on or after December 15, 2023. Prior to that date, conversion is permitted only under specific conditions, such as if the stock price exceeds 130% of the conversion price for a specified period or if the notes trade below 98% of the product of the stock price and conversion rate.
- Fundamental Change: In the event of a fundamental change, holders may require Herbalife to purchase the notes at 100% of the principal amount plus accrued interest. A make-whole premium may apply upon conversion in such events.
- Default Provisions: Holders may accelerate the principal and accrued interest if an event of default occurs.
- Registration Status: The notes and underlying shares are unregistered under the Securities Act and cannot be offered or sold in the U.S. absent registration or an exemption.
Investor Verification Checklist
- Verify the impact of the $550 million debt issuance on Herbalife's total leverage ratios and liquidity position.
- Confirm the use of proceeds from the note issuance (not explicitly detailed in this filing).
- Review the full Indenture (Exhibit 4.1) for detailed covenants and specific definitions of "fundamental change" and "event of default."
- Assess the potential dilution to existing shareholders if the notes are converted into common stock.